*Press releases are taken from the company websites.
*Titles may be translated independently.
*Please be aware that, since data is collected automatically, there is a possibility of omissions occurring.
*We would like to kindly inform you that we do not collect all press releases from companies.
| Ticker Code | Date | Title | Link |
|---|---|---|---|
| TSE:4540 | 1/16/2026 | Regarding the conclusion of a monetary loan agreement with special financial provisions | https://www.tsumura.co.jp/newsroom/newsrelease/item/20260116.pdf |
| TSE:4552 | 1/16/2026 | Information on the 44th J.P. Morgan Healthcare Conference has been posted. | https://ssl4.eir-parts.net/doc/4552/announcement/117058/00.pdf |
| TSE:4552 | 1/16/2026 | 44th J.P. Morgan Healthcare Conference Presentation Materials (English only) | https://ssl4.eir-parts.net/doc/4552/ir_material_for_fiscal_ym5/195628/00.pdf |
| TSE:4568 | 1/16/2026 | Information on the financial results announcement for the third quarter of fiscal year 2025 has been posted. | https://www.daiichisankyo.co.jp/investors/ir_news/detail/index_7376.html |
| TSE:2269 | 1/15/2026 | International University of Health and Welfare Graduate School x Ajinomoto Co., Ltd. x Meiji Co., Ltd. will open a social collaboration course on “Food, Nutrition and Health,” and will begin offering lectures at the Graduate School of Public Health in 202 | https://www.meiji.co.jp/corporate/pressrelease/2026/01_07/ |
| TSE:4901 | 1/15/2026 | Newly released long-range camera with integrated lens "FUJIFILM SX400" (Fujifilm) | https://www.fujifilm.com/jp/ja/news/list/13176 |
| BMY | 1/15/2026 | Bristol Myers Squibb Foundation Launches National Program to Bolster Mental Health Diversion Initiatives | https://news.bms.com/news/philanthropy/2026/Bristol-Myers-Squibb-Foundation-Launches-National-Program-to-Bolster-Mental-Health-Diversion-Initiatives-2026-feNgxXtwl0/default.aspx |
| TSE:2269 | 1/15/2026 | Notice regarding the results of "Next Career Special Support Measures" at Meiji Co., Ltd. (131KB) | https://www.meiji.com/pdf/news/2026/260115_01.pdf |
| TSE:4528 | 1/15/2026 | 44th Annual J.P. Morgan Healthcare Conference presentation materials have been posted on the website. | https://www.ono-pharma.com/ja/ir/library/presentations.html |
| TSE:4507 | 1/14/2026 | Results of a survey on winter infectious diseases asked of 1,200 men and women in their 20s and older nationwide | https://www.shionogi.com/jp/ja/news/2026/01/20260114.html |
| TSE:4521 | 1/14/2026 | January 14, 2026 Notice regarding donation web application cloud service (3rd report) | https://www.kaken.co.jp/inform/detail.php?id=76 |
| TSE:4528 | 1/14/2026 | Opdivo + Yervoy combination therapy received additional approval in Taiwan for adult colorectal cancer with unresectable progressive/recurrent microsatellite instability (MSI-High) or mismatch repair deficiency (dMMR) | https://www.ono-pharma.com/ja/news/20260114.html |
| TSE:4540 | 1/14/2026 | No. 6 Survey on the actual situation regarding unwellness | https://www.tsumura.co.jp/newsroom/newsrelease/2025/202601141300.html |
| TSE:4568 | 1/14/2026 | Regarding the initiation of a phase 3 clinical trial of datopotamab deruxtecan (Dato-DXd/DS-1062) in patients with non-squamous non-small cell lung cancer who are positive for the TROP2 biomarker (251.2KB).Open the PDF file in a new window. | https://www.daiichisankyo.co.jp/files/news/pressrelease/pdf/202601/20260114_J.pdf |
| TSE:4578 | 1/14/2026 | Otsuka Holdings submits a letter of commitment to obtain “Science Based Targets (SBT)” certification for the entire Otsuka Group | https://otsuka.com/jp/group_news/detail.php?id=1723 |